← Eichor
Condition: Disease Or Disorder Synced from ClinicalTrials.gov · July 31, 2026

Recruiting studies: Disease Or Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel
Phase 2 · 9 location(s) · NSABP Foundation Inc · NCT07058012A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Parti
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07138209DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Tre
Phase 3 · 250 location(s) · AstraZeneca · NCT06989112Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Phase 3 · 2 location(s) · Mercator MedSystems, Inc. · NCT04433572Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Perc
Phase 4 · 115 location(s) · Duke University · NCT06909565PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML
Phase 2 · 11 location(s) · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT06409936STICH-3.0 International Trial Consortium
NA · 1 location(s) · Vastra Gotaland Region · NCT05761067Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
Phase N/A · 2 location(s) · University of Southern California · NCT07186699Shear Wave Elastography in Differentiating Acute or Chronic Kidney Disease
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT04404114A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Pat
Phase 2 · 4 location(s) · St. Jude Children's Research Hospital · NCT07085338Assessing the Performance of GPT-4o in Evaluating the Safety of Home Environment for Older Adults
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT06962696Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · 163 location(s) · Bristol-Myers Squibb · NCT07106762An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · 147 location(s) · Novartis Pharmaceuticals · NCT05939414High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-g
Phase 2 · 1 location(s) · Jialei Wang · NCT06652048Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Metformin as Adjunct Therapy in Depression-Obesity Comorbidity: Clinical and Genetic Evaluation
NA · 2 location(s) · Riphah International University · NCT07654179Reforça't: A Community, Social, and Healthcare Program for Patients With Cardiorespiratory Conditions Upon Hospital Disc
NA · 1 location(s) · Corporació de Salut del Maresme i la Selva · NCT06897410Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth
NA · 1 location(s) · Jérôme Bouchan · NCT07469540The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT05672368A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · 48 location(s) · AbbVie · NCT07023289Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
Phase N/A · 2 location(s) · Haukeland University Hospital · NCT05388461Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT06054854A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System
NA · 1 location(s) · University of Zurich · NCT07568483A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
Phase 1 · 3 location(s) · Stingray Therapeutics · NCT06063681A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come
Phase 1 · 5 location(s) · Memorial Sloan Kettering Cancer Center · NCT04928677Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MP
Phase 1 · 1 location(s) · Mayo Clinic · NCT05549661CONDUIT™ Anterior Lumbar Interbody Fusion (ALIF) Cage System in Lumbar Degenerative Disease
Phase N/A · 1 location(s) · University College Dublin · NCT06940453A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Com
Phase 2/Phase 3 · 11 location(s) · AbbVie · NCT07581002Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels
Phase 3 · 1 location(s) · University of Brawijaya · NCT07604103
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.